6OCTOBER - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comViruses are mutating at an alarming rate, spreading and adapting to newer avenues of care, as seen by COVID-19's impact on humanity. As a result, the need for quick, accurate, and dependable diagnostic procedures has never been greater. Nanostructure-based electrical sensors have emerged as potential platforms for real-time, sensitive detection of various bio-analytes, thanks to significant developments in nanotechnology. Virologists are estimating the size and quantity of viruses using Nanopore-based Resistive-Pulse Sensing Techniques. As a result, this adds valuable information and detects all viruses and virus-related particles.Likewise, new diagnostic tools are being developed, as well as advanced techniques in the field of virology, to aid in the remediation of diseases, such as the one caused by COVID-19. Furthermore, significant advancements in molecular methods have transformed the detection of viral infections, and the efficacy of care has improved drastically. Diagnostics has been accelerated thanks to molecular technologies such as PCR and real-time PCR, which are extremely sensitive, specific, relatively affordable, and easy to automate.Our editorial board at Pharma Tech Outlook Europe has analyzed the most popular trends of the year to assist industry leaders in maneuvering in the right direction when adopting Virology solutions and services. We have filtered out the companies that genuinely set themselves leagues apart, and strive to not only outperform the rest of the pack but also solve pressing challenges prevailing in the industry. Please, let us know your thoughts.Transformation in Virus DetectionTECH OUTLOOKTECH OUTLOOKCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.OCTOBER - 21 - 2021, Vol 07 - Issue 07 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerJaxon JaseEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:David Parker
< Page 5 | Page 7 >